Medicine and Dentistry
Brain Tumor
11%
Combination Therapy
16%
Epileptic Seizure
83%
Extracellular Matrix
16%
Ganglioglioma
100%
Glioblastoma
100%
Glutamic Acid
50%
Intracranial Tumor
22%
Neoplasm
33%
Oncolytic Virotherapy
100%
Oncolytic Virus
16%
Overall Survival
16%
Patient Experience
16%
Protein Kinase B
66%
Quality of Life
16%
Reflex Epilepsy
16%
Secretion (Process)
16%
Symptom
5%
T Cell
16%
T Cell Activation
16%
Temozolomide
16%
Therapeutic Window
16%
Tumor Cell
16%
Tumor Microenvironment
16%
Virotherapy
16%
Virus
44%
Keyphrases
Adult Brain Tumors
11%
AKT Pathway
66%
AKT1
11%
Antitumor
11%
Brain Tumor
11%
Epilepsy
33%
Epileptic Seizure
11%
ERK Pathway
66%
Extracellular Glutamate
22%
Extracellular Matrix
11%
Glioblastoma
66%
Glioma
66%
Glutamate Release
11%
Hylauronic Acid
16%
Improved Efficacy
11%
Long-term Survivors
11%
Median Overall Survival
11%
Oncolytic Herpes Simplex Virus (oHSV)
22%
Oncolytic Viral Therapy
22%
Oncolytic Virotherapy
66%
Oncolytic Virus
11%
Patient Experience
11%
Presenting Symptoms
11%
Quality of Life
11%
Seizure
33%
Seizure Frequency
11%
T Cell Activation
11%
T Cells
11%
Temozolomide
11%
Therapeutic Benefits
11%
Therapeutic Efficacy
11%
Therapeutic Index
11%
Tumor
11%
Tumor Cells
11%
Tumor Immunity
22%
Tumor Killing
11%
Tumor Microenvironment
11%
Virotherapy
11%
Virus
44%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Tumor
11%
Combination Therapy
16%
Glioblastoma
100%
Glutamic Acid
50%
Intracranial Tumor
22%
Mouse
5%
Neoplasm
50%
Oncolytic Virus
16%
Overall Survival
16%
Protein Kinase B
66%
Reflex Epilepsy
16%
Seizure
5%
Symptom
5%
Temozolomide
16%
Therapeutic Window
16%
Tumor Microenvironment
16%
Virotherapy
100%